Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 23 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact23 DOIs

Add abstracts to 7 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact7 DOIs

Deposit reference lists for 2 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 23 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Análisis de la utilización de medicamentos biosimilares (10.4321/s1699-714x2020000100022)	Abstract ORCID	30.10	3
2	Hacia una Farmacia Hospitalaria Digital (10.4321/s1699-714x2020000100005)	Abstract ORCID	23.86	2
3	Medicamentos isentos de prescrição (MIP): o farmacêutico pod… (10.4321/s1699-714x20200001000013)	ORCID	21.13	6
4	Real long-term data of dupilumab in atopic dermatitis (10.4321/s1699-714x2020000100008)	ORCID	15.05	3
5	Conciliación de la medicación en las transiciones asistencia… (10.4321/s1699-714x2020000100015)	ORCID	15.05	3
6	Pharmaceutical care to patients in a smoking cessation group… (10.4321/s1699-714x2020000100023)	Abstract ORCID	15.05	1
7	¡Y llegamos al volumen 30 con el esfuerzo de muchos! (10.4321/s1699-714x2020000100001)	Abstract ORCID	0.00	0
8	Imunoprofilaxia do vírus sincicial respiratório com palivizu… (10.4321/s1699-714x20200001000010)	ORCID	0.00	0
9	Desenvolvimento de uma ferramenta para avaliação do desempen… (10.4321/s1699-714x20200001000011)	ORCID	0.00	0
10	Retiro de medicamentos antineoplásicos en un hospital nacion… (10.4321/s1699-714x20200001000012)	ORCID	0.00	0
11	Mirando hacia atrás sin ira (10.4321/s1699-714x2020000100002)	Abstract References ORCID	0.00	0
12	Fabricación a terceros: sí, pero… (10.4321/s1699-714x2020000100003)	Abstract ORCID	0.00	0
13	Terapia combinada con bevacizumab y alteplasa para el tratam… (10.4321/s1699-714x2020000100006)	ORCID	0.00	0
14	Análisis y mejora de la preparación y manipulación de medica… (10.4321/s1699-714x2020000100007)	ORCID	0.00	0
15	Evaluación de la seguridad y efectividad del intercambio de… (10.4321/s1699-714x2020000100009)	ORCID	0.00	0
16	Aseguramiento de la calidad de la cadena de frío en la distr… (10.4321/s1699-714x2020000100014)	ORCID	0.00	0
17	Protocolo de desensibilización a levofloxacino en paciente c… (10.4321/s1699-714x2020000100016)	ORCID	0.00	0
18	Fracturas múltiples y consumo inusual de pastillas Juanola®… (10.4321/s1699-714x2020000100017)	ORCID	0.00	0
19	Psoriasis pustulosa asociada a inhibidores BRAF para el trat… (10.4321/s1699-714x2020000100018)	ORCID	0.00	0
20	Prevención de pancreatitis recurrentes por deficiencia de li… (10.4321/s1699-714x2020000100019)	ORCID	0.00	0
21	Posible rotura tendinosa espontánea relacionada con el uso d… (10.4321/s1699-714x2020000100020)	ORCID	0.00	0
22	Efecto adverso psiquiátrico con lorlatinib; medicamento con… (10.4321/s1699-714x2020000100021)	ORCID	0.00	0
23	Unidades de Investigación Hospitalarias (10.4321/s1699-714x202000010004)	Abstract References ORCID	0.00	0